Clinical Trials Directory

Trials / Completed

CompletedNCT02132663

The Effects on Growth and Tolerance of a Routine Infant Formula Fed to Term Infants

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
315 (estimated)
Sponsor
Mead Johnson Nutrition · Industry
Sex
All
Age
10 Days – 14 Days
Healthy volunteers
Accepted

Summary

This clinical trial will evaluate an investigational infant formula with an alternate source of DHA to determine if it provides normal growth and if it is well tolerated by term infants as compared to a marketed routine infant formula.

Conditions

Interventions

TypeNameDescription
OTHERControl: Marketed routine infant formula
OTHERAn investigational infant formula containing an alternate source of DHA

Timeline

Start date
2014-05-01
Primary completion
2015-03-01
Completion
2015-04-01
First posted
2014-05-07
Last updated
2015-05-01

Locations

22 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02132663. Inclusion in this directory is not an endorsement.